(58 days)
No
The description explicitly states the use of "well-established algorithms" and does not mention AI, ML, or related terms.
No
This device is software for post-processing MR data to generate parametric perfusion maps, which are used by physicians for diagnosis. It does not directly provide therapy.
Yes
The software generates parametric perfusion maps (rCBV, CBF, MTT, TTP) from MR datasets, which are then used by a trained physician to yield information useful in clinical applications, indicating its role in diagnosis.
Yes
The device is described as "software" and a "plug-in" that accepts data from existing MRI systems and generates parametric maps. The description focuses entirely on software functionalities and integration with existing systems, without mentioning any accompanying hardware components developed or provided by the manufacturer.
Based on the provided information, it is unlikely that this device is an IVD (In Vitro Diagnostic). Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The description clearly states that IB Neuro™ software processes and displays dynamically acquired MR datasets. This is image processing of data obtained directly from a medical imaging modality (MRI) applied to the patient's body, not analysis of samples taken from the body.
- Intended Use: The intended use is to evaluate image intensity variations over time from MR data and generate parametric perfusion maps. This is a form of medical image analysis, not a diagnostic test performed on a biological sample.
- Input: The input is MR data, not a biological sample.
While the software provides information that can be "useful in clinical applications" and interpreted by a physician, this does not automatically classify it as an IVD. It is a tool for analyzing medical images, which is a different category of medical device.
The fact that it is compared to predicate devices that are also software options for MR scanners further supports the conclusion that it is not an IVD.
N/A
Intended Use / Indications for Use
IB Neuro™ software allows the post-processing and display of dynamically acquired MR datasets to evaluate image intensity variations over time. IB Neuro™ v1.0 plug-in accepts data from existing MRI systems, performs quality control checks and generates parametric perfusion maps such as Relative Cerebral Blood Volume (rCBV), Cerebral Blood Flow (CBF), Mean Transit Time (MTT) and Time to Peak (TTP) and sends the maps to a PACS for subsequent viewing. These images when interpreted by a trained physician may yield information useful in clinical applications. Our advanced technology is designed to be compliant with healthcare standards such as DICOM and is easily and rapidly integrated into existing medical image visualization applications.
Product codes
LNH, LLZ
Device Description
IB Neuro "" OsiriX Plugin is software designed to analvze dynamically acquired datasets. Using well-established algorithms, parametric perfusion maps can be generated such as Relative Cerebral Blood Volume (rCBV), Cerebral Blood Flow (CBF), Mean Transit Time (MTT) and Time to Peak (TTP). The strength of our software is its ability to extend the productivity of any existing viewer, CAD workstation or PACS via a platform-independent base library that allows for quick and seamless integration into existing server and workstation applications. It also includes other critical features such as:
- Enables rapid creation of a complete array of critical perfusion parameter o maps of rCBV, CBF, MTT, TTP
- o Automated correction of contrast agent leakage for rCBV maps
- o Automated brain mask generation
- Ability to normalize parameters to normal appearing white matter (NAWM) o
- o Automated report generation
- View dynamic signal time course on a per-voxel basis o
- Interactive Arterial Input Function (AIF) selection o
- o Automatic export of perfusion parameter maps to DICOM images within the same study
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
MR
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
trained physician / Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance testing included software validation, verification and testing per FDA's software validation guidance.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1000 Magnetic resonance diagnostic device.
(a)
Identification. A magnetic resonance diagnostic device is intended for general diagnostic use to present images which reflect the spatial distribution and/or magnetic resonance spectra which reflect frequency and distribution of nuclei exhibiting nuclear magnetic resonance. Other physical parameters derived from the images and/or spectra may also be produced. The device includes hydrogen-1 (proton) imaging, sodium-23 imaging, hydrogen-1 spectroscopy, phosphorus-31 spectroscopy, and chemical shift imaging (preserving simultaneous frequency and spatial information).(b)
Classification. Class II (special controls). A magnetic resonance imaging disposable kit intended for use with a magnetic resonance diagnostic device only is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 892.9.
0
EXHIBIT #1
510(k) SUMMARY
This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of SMDA 1990 and 21 CFR §807.92.
The assigned 510(k) number is:
1. Submitter's Identification:
MAY 1 5 2008
Imaging Biometrics, LLC 1035 Katherine Drive Elm Grove, WI 53122
Contact Person Michael Schmainda Phone: (262) 385-1796 Email: mike@imagingbiometrics.com
Date Summary Prepared: 3/4/2008
2. Name of the Device:
| Trade Name: | IB Neuro™ v1.0 |
|---|---|
| Classification Name: | |
| Classification: | |
| Product Code: | MR Diagnostic Device Accessory: 21 CFR 892.1000 |
| Class II | |
| LNH | |
| Classification Name: | Picture Archiving and Communication Systems |
| 21 CFR 892.2050 | |
| Classification: | Class II |
| Product Code: | LLZ |
3. Common or Usual Name:
IB Neuro™ 1.0 / PACS device
4. Predicate Device Information:
IB Neuro™ is substantially equivalent to the following legally marketed devices that are currently cleared by the FDA:
1
| 510(k) | Trade Name | Manufacturer |
|---|---|---|
| K073167 | BrainStat Software Option for GE | |
| Signa MR Scanners | GE Medical Systems | |
| 3200 N. Grandview Blvd. W-827 | ||
| Waukesha, WI 53188 | ||
| K061429 | Dynamic MRI Software Option for | |
| C-Scan, E-ScanXQ and E-Scan | ||
| Opera | ESAOTE S.p.A. | |
| Via Siffredi, 58 | ||
| 16153 Genova - Italy | ||
| K984224 | Perfusion Package for Magnetom | |
| Vision and Symphony MR Systems | Siemens Medical Systems, Inc. | |
| 186 Wood Avenue South | ||
| Iselin, NJ 08830 |
5. Device Description:
IB Neuro "" OsiriX Plugin is software designed to analvze dynamically acquired datasets. Using well-established algorithms, parametric perfusion maps can be generated such as Relative Cerebral Blood Volume (rCBV), Cerebral Blood Flow (CBF), Mean Transit Time (MTT) and Time to Peak (TTP). The strength of our software is its ability to extend the productivity of any existing viewer, CAD workstation or PACS via a platform-independent base library that allows for quick and seamless integration into existing server and workstation applications. It also includes other critical features such as:
- Enables rapid creation of a complete array of critical perfusion parameter o maps of rCBV, CBF, MTT, TTP
- o Automated correction of contrast agent leakage for rCBV maps
- o Automated brain mask generation
- Ability to normalize parameters to normal appearing white matter (NAWM) o
- o Automated report generation
- View dynamic signal time course on a per-voxel basis o
- Interactive Arterial Input Function (AIF) selection o
- o Automatic export of perfusion parameter maps to DICOM images within the same study
6. Intended Use:
IB Neuro™ software allows the processing and display of dynamically acquired MR datasets to evaluate image intensity variations over time. IB Neuro™ v1.0 plug-in accepts data from existing MRI systems, performs quality control checks
2
and generates parametric perfusion maps such as Relative Cerebral Blood Volume (rCBV), Cerebral Blood Flow (CBF), Mean Transit Time (MTT) and Time to Peak (TTP) and sends the maps to a PACS for subsequent viewing. These images when interpreted by a trained physician may vield information useful in clinical applications. Our advanced technology is designed to easily and rapidly integrate into existing medical image visualization applications.
7. Substantial Equivalence/ Comparison to Predicate Devices:
The intended use and performance characteristics for IB Neuro™ are substantially equivalent to the predicate devices listed in section 4 above for image analysis and processing and generation of parametric maps to provide additional information bevond standard imaging.
8. Discussion of Non-Clinical Tests Performed for Determination of Substantial Equivalence are as follows:
Performance testing included software validation, verification and testing per FDA's software validation guidance.
9. Discussion of Clinical Tests Performed:
N/A
10. Conclusions:
The IB Neuro™ 1.0 device has a similar intended use and similar characteristics as the predicate devices. Moreover, documentation supplied in this submission demonstrates that any difference in technological characteristics do not raise any new questions of safety or effectiveness. Thus, the IB Neuro™ device is substantially equivalent to predicate devices.
3
Image /page/3/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle with three stripes forming its wing and tail feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" is arranged in a circular fashion around the eagle.
DEPARTMENT OF HEALTH & HUMAN SERVICES
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAY 1 5 2008
Mr. Michael Schmainda CEO Imaging Biometrics, LLC 1035 Katherine Dr. ELM GROVE WI 53122
Re: K080762
Trade/Device Name: IB Neuro™ v1.0 Regulation Number: 21 CFR 892.1000 Regulation Name: Magnetic resonance diagnostic device Regulatory Class: II Product Code: LNH Dated: March 17, 2008 Received: March 18, 2008
Dear Mr. Schmainda:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic act (Act) that do not require approval of a premarket approval application (PMA), You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and i adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
4
Please be advised that FDA.'s issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements act threact or any Federal statutes and regulations administered by other Federal agencies. You nust comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to I ogally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Crant of Crane of the following numbers, based on the regulation number at the top of this letter.
| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 |
|---|---|---|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device 2-so-zing (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrb/industry/support/index.html.
Sincerely yours.
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
Exhibit B
Indications for Use
510(k) Number (if known):
IB Neuro™ v1.0
Indications For Use:
Device Name:
IB Neuro™ software allows the post-processing and display of dynamically acquired MR datasets to evaluate image intensity variations over time. IB Neuro™ v1.0 plug-in accepts data from existing MRI systems, performs quality control checks and generates parametric perfusion maps such as Relative Cerebral Blood Volume (rCBV), Cerebral Blood Flow (CBF), Mean Transit Time (MTT) and Time to Peak (TTP) and sends the maps to a PACS for subsequent viewing. These images when interpreted by a trained physician may yield information useful in clinical applications. Our advanced technology is designed to be compliant with healthcare standards such as DICOM and is easily and rapidly integrated into existing medical image visualization applications.
Prescription Use: X (Per 21 CFR 801 Subpart D)
OR
Over-The Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number K080762